Back to Choline Bitartrate

Safety question

Is Choline Bitartrate safe?

Yes — within typical dose ranges, by published evidence. Choline Bitartrate scores 5/5 on our safety scale. Documented adverse reactions are minor, dose-related, and reversible on stopping. Healthy adults at standard doses tolerate it well in the clinical literature.

Safety score

5 / 5

Evidence grade

B

Severe reactions on file

0

Pubmed cites

1200

Key facts

typical dose
250–1000 mg
dose frequency
1-2 doses
timing
AM
with food
with meal
safety score
5/5
evidence grade
B
class
cholinergic
PubMed citations
1200
legal status (US)
Over-the-counter
legal status (UK)
Over-the-counter
legal status (EU)
Over-the-counter
legal status (AU)
Over-the-counter
primary mechanism
Choline conjugated with tartaric acid.

Common side effects

Uncommon side effects

Who should not take Choline Bitartrate

What "safe" means here

Our safety scoring reflects (a) published clinical and observational literature on healthy-adult use at standard supplement doses, (b) the spectrum of adverse-event reports in the medical and supplement-pharmacovigilance record, and (c) the regulatory status across major jurisdictions. It does notreflect long-term outcomes in populations that haven’t been studied, and it does not substitute for clinical judgement applied to your individual situation.

A 5/5 score does not mean “no risk” — it means risk has been quantified as low in healthy adults at usual doses. Idiosyncratic and allergic reactions are possible with virtually any compound, including those we rate highest.

Full mechanism, citations, and dose guidance for Choline Bitartrate are on the main reference page — see Choline Bitartrate. For the dose-by-dose breakdown, see Choline Bitartrate dosage. To check stack interactions, use the interaction checker.

This page is informational. It is not medical advice and does not establish a clinician-patient relationship. Individual risk varies with genetics, medications, pre-existing conditions, and dose. Always consult a qualified clinician before starting a new compound. See our full disclaimer and terms.